93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details


臨床試験数 : 298 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05624294
(ClinicalTrials.gov)
December 19, 202214/11/2022Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy SubjectsA Phase I, Randomized, Double-blind, Placebo-controlled, Single Ascending Does/ Mulelple Ascending Does Study of CS0159 to Evaluate the Safety, Tolerability, Pharmacokynetics, and Food Effect in Healthy SubjectsPrimary Biliary CholangitisDrug: CS0159;Drug: PlaceboCascade Pharmaceuticals, IncNULLRecruiting18 Years55 YearsAll36Phase 1China